Literature DB >> 31990258

Risk Limits in Fair Subject Selection.

Robert Steel1.   

Abstract

Entities:  

Year:  2020        PMID： 31990258      PMCID： PMC7039310          DOI： 10.1080/15265161.2019.1701733

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  8 in total

1.  Two dogmas of research ethics and the integrative approach to human-subjects research.

Authors:  Alex John London
Journal:  J Med Philos       Date:  2007 Mar-Apr

2.  A framework for risk-benefit evaluations in biomedical research.

Authors:  Annette Rid; David Wendler
Journal:  Kennedy Inst Ethics J       Date:  2011-06

3.  Four Faces of Fair Subject Selection.

Authors:  Douglas MacKay; Katherine Witte Saylor
Journal:  Am J Bioeth       Date:  2020-02       Impact factor: 11.229

4.  Reconceptualising risk-benefit analyses: the case of HIV cure research.

Authors:  Robert Steel
Journal:  J Med Ethics       Date:  2019-11-15       Impact factor: 2.903

5.  Can research at the end of life be a useful tool to advance HIV cure?

Authors:  Sara Gianella; Jeff Taylor; Timothy R Brown; Andy Kaytes; Cristian L Achim; David J Moore; Susan J Little; Ronald J Ellis; Davey M Smith
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

6.  A global survey of HIV-positive people's attitudes towards cure research.

Authors:  R Simmons; M Kall; S Collins; G Cairns; S Taylor; M Nelson; S Fidler; K Porter; J Fox
Journal:  HIV Med       Date:  2016-05-11       Impact factor: 3.180

7.  An activist's argument that participant values should guide risk-benefit ratio calculations in HIV cure research.

Authors:  David Evans
Journal:  J Med Ethics       Date:  2017-01-06       Impact factor: 2.903

8.  The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction.

Authors:  Nir Eyal
Journal:  J Med Ethics       Date:  2016-05-23       Impact factor: 2.903
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.